bluebird bio, Inc. (BLUE)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 03:36PM EST. Market open.
| Previous close | 6.11 |
| Open | 6.15 |
| Bid | 6.32 x 900 |
| Ask | 6.33 x 2200 |
| Day's range | 6.15 - 6.42 |
| 52-week range | 2.87 - 8.58 |
| Volume | |
| Avg. volume | 3,757,681 |
| Market cap | 652.274M |
| Beta (5Y monthly) | 0.98 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -10.43 |
| Earnings date | 02 Mar 2023 - 06 Mar 2023 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 7.33 |
- Simply Wall St.
bluebird bio, Inc. (NASDAQ:BLUE) is favoured by institutional owners who hold 58% of the company
Every investor in bluebird bio, Inc. ( NASDAQ:BLUE ) should be aware of the most powerful shareholder groups. And the...
- Zacks
Zacks.com featured highlights include bluebird bio, Pros Holdings and Norwegian Cruise Line
bluebird bio, Pros Holdings and Norwegian Cruise Line are part of the Zacks Screen of the Week article.
- Motley Fool
Better Biotech Buy: Bluebird Bio or CRISPR Therapeutics?
Last year paved the way for a potential breakthrough this year for both gene-editing biotech companies.
© 2023 Yahoo. All rights reserved.
